RDY

Dr Reddys Laboratories
$11.77
−$0.02 (−0.17%)Jul 27, 2026
7.2GoodMoatMint rating

MoatMint rates Dr Reddys Laboratories (RDY) 7.2 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 7.6 out of 10.

Key metrics

The numbers that frame RDY today
Market cap
$9.82B
P/E (TTM)
22.2
EV / FCF
54.3
Gross margin
52.8%
EV / Sales
3.0
ROIC
18.4%
Div yield
0.77%
Debt / equity
0.2
52wk Low
$11.30
52wk High
$15.51

RDY stock rating

How RDY scores on quality, value, growth, momentum and financial health
7.2out of 10
Good overallHealthy business, fair priceTop 28% of ~5,000 US stocks
QualityGood7.6/10
GrowthNo scoren/a/10
MomentumGood6.0/10
ValueGood6.8/10
Financial HealthNo scoren/a/10

Growth

Revenue and earnings trend for RDY
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about RDY
Is Dr Reddys Laboratories a good buy?
Yes. Dr Reddys Laboratories has excellent quality and strong momentum. Both signals support the setup. We think Dr Reddys Laboratories is selling at a fair price.
What is the market capitalization of RDY?
Dr Reddys Laboratories's market capitalization is $9.82B.
What is the P/E ratio for RDY stock?
Dr Reddys Laboratories's current P/E ratio is 22.2.
What is the 52-week high for RDY stock?
The 52-week high for Dr Reddys Laboratories is $15.51. The current close of $11.77 is 24.1% below that high.
What is the 52-week low for RDY stock?
The 52-week low for Dr Reddys Laboratories is $11.30. The current close of $11.77 is 4.2% above that low.
Does RDY stock pay dividends?
Dr Reddys Laboratories pays a dividend. The latest dividend per share in the company data is $0.09, which implies a yield of 0.77% based on the current close.
What is the Debt / Equity ratio for RDY?
Dr Reddys Laboratories's Debt / Equity ratio is 0.21.